CN103961637A - Chinese medicinal composition for treatment of lumbar disc herniation - Google Patents
Chinese medicinal composition for treatment of lumbar disc herniation Download PDFInfo
- Publication number
- CN103961637A CN103961637A CN201310041800.3A CN201310041800A CN103961637A CN 103961637 A CN103961637 A CN 103961637A CN 201310041800 A CN201310041800 A CN 201310041800A CN 103961637 A CN103961637 A CN 103961637A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- treatment
- rhizoma
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a Chinese medicinal composition for treatment of lumbar disc herniation. The Chinese medicinal composition is composed of the following components by weight: 100-120g of cassia twig, 150-200g of radix clematidis, 100-120g of full angelica, 150-200g of Japanese honeysuckle stem, 100-120g of stir-fried radix paeoniae alba, 100-120g of Rhizoma Cibotii slices, 150-200g of Herba Lycopodii, 150-200g of large Ligusticum wallichii, 200-300g of raw astragalus, 150-200g of Notopterygium Roots, 100-120g of radix saposhnikoviae, 100-120g of turmeric, 100-120g of gentiana macrophylla, 100-120g of ground beeltle, 100-120g of centipede, 100-120g of Rhizoma Corydalis, 100-120g of fructus aurantii, 100-120g of dried tangerine peel, 100-120g of safflower, 100-120g of frankincense and myrrh, and 100-120g of radix rehmanniae. The Chinese medicinal composition for treatment of lumbar disc herniation provided by the invention is formed according to the characteristics of traditional Chinese medicinal theories of China, and is prepared from drugs with the efficacy of activating blood to remove stasis, warming and activating channels, activating collaterals and relieve pain. The prescription raw materials involved in the invention are mixed without destroying the original effective components of crude medicinal materials so as to be prepared into a capsule, which is a specific drug for treatment of lumbar disc herniation.
Description
Technical field
The invention belongs to the herbal mixture for the treatment of prolapse of lumbar intervertebral disc, be especially a kind ofly used for the treatment of the waist shank pain that prolapse of lumbar intervertebral disc pressuring neural root causes, various arthralgias are also had to good curative effect simultaneously.Trade name is that lumbago is more healthy and free from worry.
Background technology
Prolapse of lumbar intervertebral disc is one of clinical common frequently-occurring disease, because annulus fibrosus disci intervertebralis breaks, outstanding, the stimulation of vertebral pulp or pressuring neural root and the caused a kind of clinical syndrome of cauda equina nerve." numbness " disease category that belongs to the traditional Chinese medical science, is manyly because of due to blood stasis, cold-damp, damp and hot evil numbness resistance passages through which vital energy circulates, to take lumbago and skelalgia as principal character, is the serious disease of harm people ' s health and life.The object of the present invention is to provide: a kind of short treating period, expense be low, without mono-kind of the < < not recurring after operating on (treatment by Chinese herbs), recovering, treat the Chinese medicine composition > > of prolapse of lumbar intervertebral disc, the instructions of taking of medicine of the present invention is: only take 1g at every turn, two of capsules, by temperature, take happily, clinical sign and the symptom taken after 3 days are obviously improved, within one week, are substantially cured, basic healing after two weeks.The present invention is the optimal drug of thoroughly treating prolapse of lumbar intervertebral disc, is also the current new drug of state-of-the-art treatment prolapse of lumbar intervertebral disc in the world.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, by the component of following weight parts, formed: 100～120 grams of Ramulus Cinnamomi, 150～200 grams of Radix Clematidis, 100～120 grams of Radix Angelicae Sinensis, 150～200 grams of Caulis Loniceraes, 100～120 grams of Radix Paeoniae Alba (parched)s, 100～120 grams of Rhizoma Cibotii sheets, 150～200 grams of Herba Lycopodiis, 150～200 grams of large Rhizoma Chuanxiongs, 200～300 grams of Radix Astragali, 150～200 grams of Rhizoma Et Radix Notopterygiis, 100～120 grams of Radix Saposhnikoviaes, 100～120 grams, Rhizoma Curcumae Longae, 100～120 grams of Radix Gentianae Macrophyllae, 100～120 grams of the worms of spraining, 100～120 grams of Scolopendras, 100～120 grams of corydalis tubers, 100～120 grams of Fructus Aurantiis, 100～120 grams of Pericarpium Citri Reticulataes, 100～120 grams, Flos Carthami, breast does not have 100～120 grams, 100～120 grams, the Radix Rehmanniae.The Chinese medicine composition that is used for the treatment of prolapse of lumbar intervertebral disc provided by the present invention is to form according to the group of features of motherland's tcm theory, adopts blood circulation promoting and blood stasis dispelling, promoting the flow of QI-blood by warming the meridian, the ingredients of activating collaterals to relieve pain.Prescription raw material of the present invention is mixed and made into capsule on the basis of original active ingredient of not destroying raw medicinal herbs, is the specific medicament for the treatment of prolapse of lumbar intervertebral disc.
Claims (4)
1. a Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, it is characterized in that component by following weight parts forms: 100～120 grams of Ramulus Cinnamomi, 150～200 grams of Radix Clematidis, 100～120 grams of Radix Angelicae Sinensis, 150～200 grams of Caulis Loniceraes, 100～120 grams of Radix Paeoniae Alba (parched)s, 100～120 grams of Rhizoma Cibotii sheets, 150～200 grams of Herba Lycopodiis, 150～200 grams of large Rhizoma Chuanxiongs, 200～300 grams of Radix Astragali, 150～200 grams of Rhizoma Et Radix Notopterygiis, 100～120 grams of Radix Saposhnikoviaes, 100～120 grams, Rhizoma Curcumae Longae, 100～120 grams of Radix Gentianae Macrophyllae, 100～120 grams of the worms of spraining, 100～120 grams of Scolopendras, 100～120 grams of corydalis tubers, 100～120 grams of Fructus Aurantiis, 100～120 grams of Pericarpium Citri Reticulataes, 100～120 grams, Flos Carthami, breast does not have 100～120 grams, 100～120 grams, the Radix Rehmanniae.
2. the Chinese medicine composition for the treatment of cerebral thrombosis according to claim 1, wherein the weight proportion of each component is: 100 grams of Ramulus Cinnamomi, 200 grams of Radix Clematidis, 100 grams of Radix Angelicae Sinensis, 200 grams of Caulis Loniceraes, 120 grams of Radix Paeoniae Alba (parched)s, 120 grams of Rhizoma Cibotii sheets, 200 grams of Herba Lycopodiis, 200 grams of large Rhizoma Chuanxiongs, 300 grams of Radix Astragali, 150 grams of Rhizoma Et Radix Notopterygiis, 100 grams of Radix Saposhnikoviaes, 100 grams, Rhizoma Curcumae Longae, 100 grams of Radix Gentianae Macrophyllae, 120 grams of the worms of spraining, 120 grams of Scolopendras, 100 grams of corydalis tubers, Fructus Aurantii 100,100 grams of Pericarpium Citri Reticulataes, 120 grams, Flos Carthami, breast do not have 120 grams of 120 grams, the Radix Rehmanniae.
3. according to the Chinese medicine composition of the treatment cerebral thrombosis described in claim 1-2 any one, it is characterized in that said composition is capsule.
4. the preparation method of the cardiopathic Chinese medicine composition for the treatment of according to claim 2, after it is characterized in that the crude drug of each component to be dried, is pulverized and mixed smalls encapsulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310041800.3A CN103961637A (en) | 2013-01-24 | 2013-01-24 | Chinese medicinal composition for treatment of lumbar disc herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310041800.3A CN103961637A (en) | 2013-01-24 | 2013-01-24 | Chinese medicinal composition for treatment of lumbar disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103961637A true CN103961637A (en) | 2014-08-06 |
Family
ID=51231957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310041800.3A Pending CN103961637A (en) | 2013-01-24 | 2013-01-24 | Chinese medicinal composition for treatment of lumbar disc herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103961637A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048900A (en) * | 2009-11-09 | 2011-05-11 | 景松森 | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion |
-
2013
- 2013-01-24 CN CN201310041800.3A patent/CN103961637A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048900A (en) * | 2009-11-09 | 2011-05-11 | 景松森 | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion |
Non-Patent Citations (2)
| Title |
|---|
| 张新华等: "腰椎间盘突出症治疗常用中药及组方规律", 《中国民间疗法》 * |
| 李文豪: "中医对腰椎间盘突出症的认识", 《甘肃中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN100488549C (en) | Externally applied medicament for treating rheumatism | |
| CN101637585A (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103585299A (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
| CN102648961A (en) | Medicine for treating ischemic stroke sequela | |
| CN101244245A (en) | Chinese medicine composition for blood circulation activating and stasis removing | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN105169076A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
| CN104147502A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition | |
| CN103599496A (en) | Traditional Chinese medicine for treatment of chronic gastritis | |
| CN103316298A (en) | Traditional Chinese composition for treating arthralgia | |
| CN104383495A (en) | Drug for treating neural injury caused by chemotherapy and preparation method of drug | |
| CN103656462A (en) | Traditional Chinese medicine for treating panasthenia | |
| CN102451449A (en) | Capsule for warming channel to remove coldness | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN102204978B (en) | Medicinal composition for treating cancer pain and preparation thereof | |
| CN101138625A (en) | Chinese medicine composition for treating omarthritis | |
| CN103690898A (en) | Traditional Chinese medicine for treating bronchitis | |
| CN101721479A (en) | Chinese herbal medicine preparation for treating rheumatalgia | |
| CN104138523A (en) | Chinese medicinal composition for treatment of lumbar disc herniation and lumbar vertebra hyperosteogeny and preparation method thereof | |
| CN104258299A (en) | Traditional Chinese medicine for treating mumps | |
| CN103961637A (en) | Chinese medicinal composition for treatment of lumbar disc herniation | |
| CN104027764A (en) | Medicine for treating rheumatoid bone diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140806 |